Guardant Health closes $550M convertible notes offering
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardant Health, Inc. (GH) completed a private offering of $550 million aggregate principal amount of 0% convertible senior notes due May 15, 2032, including the initial purchasers’ fully exercised option for an additional $50 million. The senior, unsecured notes bear no regular interest, and the principal does not accrete. Net proceeds were approximately $538.3 million.
Guardant Health used approximately $501.7 million of net proceeds to repurchase approximately $395.2 million aggregate principal amount of its 0% notes due 2027. It used the remaining net proceeds, plus cash on hand, to fund the $51.7 million cost of capped-call transactions, which are expected generally to reduce potential dilution, subject to a cap. The notes’ initial conversion rate is 4.7858 shares per $1,000 principal amount, equivalent to an initial conversion price of approximately $208.95 per share, a 35.0% premium to the November 11, 2026 last reported share price of $154.78. A maximum of 3,553,385 shares may be issued upon conversion based on the initial maximum conversion rate. The capped calls’ initial cap price is $309.56 per share.
Filing Explained
Under the issued notes, holders may convert before February 15, 2032 only when specified conditions apply; afterward they may convert until two trading days before maturity, while Guardant Health chooses whether settlement is in cash, shares, or a mix.
8-K Event Classification
Key Figures
Key Terms
0% Convertible Senior Notes due 2032 financial
initial conversion rate financial
capped call transactions financial
provisional redemption financial
cleanup redemption financial
Rule 144A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much did Guardant Health (GH) raise in its 2032 convertible notes offering?
How is GH using the proceeds from its convertible notes offering?
What is the conversion price for GH’s 2032 notes?
When can GH redeem its 2032 convertible notes?
AI-generated analysis. How Rhea-AI works. Not financial advice.